03860313falsemedical research2024-11-012025-10-31http://www.companieshouse.gov.uk/2024-10-31http://www.companieshouse.gov.uk/cd:Director12024-11-012025-10-31http://www.companieshouse.gov.uk/cd:AuditExemptWithAccountantsReport2024-11-012025-10-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2025-10-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2024-10-31http://www.companieshouse.gov.uk/2024-11-012025-10-31http://www.companieshouse.gov.uk/2024-10-31http://www.companieshouse.gov.uk/2025-10-31http://www.companieshouse.gov.uk/cd:FullAccounts2024-11-012025-10-31http://www.companieshouse.gov.uk/cd:PrivateLimitedCompanyLtd2024-11-012025-10-31http://www.companieshouse.gov.uk/cd:Micro-entities2024-11-012025-10-31iso4217:GBPxbrli:sharesxbrli:pure
Registered number: 03860313

Oxford Medical Technology Ltd

ACCOUNTS
FOR THE YEAR ENDED 31/10/2025

Prepared By:
Apple Tree Accountancy Ltd
Fox Fold House
East Hanney
Wantage
Oxon.
OX12 0HS

Oxford Medical Technology Ltd

Registered Number: 03860313
BALANCE SHEET AT 31/10/2025
20252024
££
Current assets41,63739,142
Creditors: amounts falling due within one year(35,389)(35,389)
Net Current Assets6,2483,753
Total assets less current liabilities6,2483,753
Net Assets6,2483,753
Capital and reserves6,2483,753
Average Number of Employees
During the year the average number of employees was 0.
Company information
registered in EW - England and Wales, registered number 03860313. Registered office 14 Gaysham Avenue, Gants Hill, Ilford, Essex, IG2 6TH
For the year ending 31/10/2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the micro-entities regime.
These accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Approved by the board on 21/04/2025 and signed on their behalf by
.............................
Dr. Fares Mayia
Director